Important 2026 Update: Sequence Is Now Form Health
Patients searching for "Sequence GLP-1" or "Sequence Health" in 2026 should be aware that Sequence has rebranded to Form Health. The platform operates under the Form Health brand as of mid-2025, though many patients and search results still use the Sequence name. All references to Sequence in this comparison should be understood as Form Health (formhealth.co). Pricing and program details should be verified directly at Form Health's current website.
Understanding the Two Fundamentally Different Premium Models
Sequence/Form Health and Calibrate represent two distinct philosophies about what "premium" GLP-1 care means — and understanding that distinction is essential for evaluating whether either platform is right for you.
Sequence/Form Health's premium is clinical. The platform's distinguishing feature is board-certified obesity medicine specialists — physicians who have passed the American Board of Obesity Medicine (ABOM) examination and dedicated their careers specifically to the treatment of obesity as a complex, chronic disease. This specialized clinical credential matters most for patients with high-complexity medical situations: BMI above 40, multiple obesity-related comorbidities, histories of treatment-resistant obesity, or complex medication interactions that require expert management.
Calibrate's premium is programmatic. Calibrate's approach is less about physician specialization and more about a comprehensive lifestyle transformation framework — a structured year-long program covering nutrition, sleep, exercise, and emotional health alongside GLP-1 medication access. Critically, Calibrate's model is primarily oriented around brand-name GLP-1 medications through insurance coordination (Wegovy, Zepbound), not compounded alternatives. The $1,649 program fee covers the coaching and insurance navigation infrastructure; the medication cost is separate and depends on insurance coverage.
These are not just different tiers of the same service — they are solving different problems for different patient profiles. Getting them confused leads to paying for the wrong premium.
Sequence / Form Health: Deep Dive
Sequence / Form Health — Clinical Excellence Model
Form Health (formerly Sequence) positions itself at the clinical quality end of the GLP-1 telehealth spectrum. The platform's board-certified obesity medicine specialists bring formal subspecialty training in obesity as a chronic disease — a meaningful credential that reflects deep, dedicated expertise with GLP-1 pharmacology, metabolic complications of obesity, and complex dose management. Obesity medicine board certification requires passing a rigorous examination and demonstrates a level of specialized knowledge beyond general internal medicine or family practice.
The platform offers compounded semaglutide as its primary medication pathway, with approximately $179/month on an annual plan — a committed approach that implies patients are enrolling for a meaningful treatment course rather than testing GLP-1 month-to-month. For patients with insurance who want to pursue brand-name Wegovy or Zepbound, Sequence/Form Health's physician network provides the clinical credibility to support prior authorization applications more convincingly than generalist providers.
The limitation is price: $179/month annual ($2,148/year) for compounded semaglutide is higher than several comparable platforms including Luma Health at $197/month flat with no annual commitment requirement. The clinical specialization premium is real and justified for high-complexity patients, but for patients with straightforward weight management needs, the additional cost may not translate to meaningfully better outcomes.
✓ Strengths
- ✓ Board-certified obesity medicine MDs
- ✓ Highest clinical credential in field
- ✓ Expert dose management and complex case handling
- ✓ Strong prior auth support for brand-name
- ✓ Compounded GLP-1 without insurance
✗ Limitations
- ✗ Higher price than most compounded alternatives
- ✗ Annual commitment implied by annual pricing
- ✗ Clinical premium underutilized by straightforward cases
- ✗ Verify current tirzepatide availability
- ✗ Rebranding (Sequence → Form Health) creates search confusion
Calibrate: Deep Dive
Calibrate — Comprehensive Metabolic Reset Program
Calibrate operates on a fundamentally different model than most GLP-1 telehealth platforms. Where most providers are primarily in the medication access business — getting patients the right GLP-1 prescription at a sustainable price — Calibrate is in the behavioral transformation business, with GLP-1 as one component of a broader year-long metabolic reset program.
The four-pillar framework (food, sleep, exercise, emotional health) is genuinely comprehensive and addresses the behavioral dimensions of obesity that medication alone cannot resolve. Calibrate's philosophy — that long-term weight maintenance requires habit change, not just appetite suppression — is clinically sound. The STEP 4 trial demonstrated clearly that GLP-1 weight loss reverses rapidly when medication is stopped, underscoring the importance of behavioral infrastructure for maintenance. Calibrate's program is designed with that clinical reality in mind.
Crucially, Calibrate's model is built around brand-name GLP-1 through insurance — not compounded medication. The $1,649 program fee covers the coaching, insurance navigation, and program infrastructure. The medication cost is separate and entirely dependent on whether your insurance covers Wegovy or Zepbound and what your copay is. For insured patients who successfully receive prior authorization and apply a savings card, total annual cost can be competitive. For cash-pay patients or those without insurance covering GLP-1, Calibrate's model is significantly more expensive than compounded alternatives.
✓ Strengths
- ✓ Most comprehensive behavioral coaching in GLP-1 market
- ✓ 4-pillar approach addresses long-term maintenance
- ✓ Brand-name GLP-1 + savings card can be cost-effective for insured
- ✓ Structured accountability framework
- ✓ Year-long program designed for sustainable habit formation
✗ Limitations
- ✗ $1,649 program fee paid upfront — high financial commitment
- ✗ Medication cost depends entirely on insurance approval
- ✗ Not designed for cash-pay compounded GLP-1 patients
- ✗ Year commitment reduces flexibility if the program isn't right for you
- ✗ Coaching premium only valuable if you consistently engage with it
The Annual Cost Reality: What You Actually Pay
Form Health (Sequence) — Cash-Pay Compounded
Calibrate — Insured Brand-Name Pathway
★ Luma Health — Flat-Rate Compounded
Full Three-Way Comparison
| Factor | Form Health (Sequence) | Calibrate | Luma Health |
|---|---|---|---|
| Sema monthly cost | ~$179/mo (annual) | $1,649 fee + insurance copay | $197/mo flat |
| Medication type | Compounded (+ brand pathway) | Brand-name Wegovy/Zepbound | Compounded sema + tirz |
| Insurance required | No (for compounded) | Yes — model depends on it | ✓ No |
| Clinical specialization | ✓ Board-certified obesity medicine MDs | Metabolic health MDs | Wasef Health, PC (GLP-1 focused) |
| Behavioral coaching | Limited | ✓ Structured 4-pillar (food, sleep, exercise, emotional) | Not included |
| Annual commitment | Annual pricing implies commitment | Yes — year-long program ($1,649 upfront) | ✓ None — cancel anytime |
| Tirzepatide access | Verify directly | Zepbound (via insurance) | ✓ $297/mo flat |
| Pharmacy verifiable | Verify compounding pharmacy | Brand retail pharmacy | ✓ VialsRX, TX #35264 |
| Cost predictability | Annual rate — predictable | High variance — insurance-dependent | ✓ Flat rate — no surprises |
| Best for | Complex metabolic cases needing obesity medicine specialist | Insured patients wanting brand GLP-1 + structured coaching | Most cash-pay patients who want the best value |
Who Actually Needs a Premium Provider?
Honest Assessment: When Premium Is Worth It vs. When It's Not
Premium IS Worth Considering For...
- ● BMI above 40 with multiple obesity-related comorbidities (T2D, sleep apnea, hypertension, dyslipidemia)
- ● History of treatment-resistant obesity or multiple failed weight loss attempts
- ● Previous bariatric surgery with complex metabolic context
- ● Complex medication interactions requiring expert management (Sequence/Form Health specifically)
- ● Insured patients with good Wegovy/Zepbound coverage who want structured behavioral support (Calibrate specifically)
- ● Patients who will genuinely engage with comprehensive coaching and believe behavioral structure is essential to their success
Premium Is NOT Necessary For...
- ● BMI 27–40 with relatively straightforward medical history
- ● First-time GLP-1 patients without complex comorbidities
- ● Cash-pay patients without usable insurance coverage for brand-name GLP-1
- ● Self-directed patients who will not consistently use behavioral coaching programs
- ● Patients who need month-to-month flexibility and cannot commit to 12-month programs
- ● Patients whose primary need is reliable GLP-1 access at a price they can sustain for 12+ months — where Luma Health at $197/month flat is both clinically appropriate and financially sustainable
Frequently Asked Questions
Is Sequence now called Form Health?
Yes. Sequence Health rebranded to Form Health in mid-2025. The platform operates at formhealth.co. Many patients and search results still reference the Sequence name due to the established brand recognition. If you are searching for Sequence GLP-1, Sequence Health, or Sequence semaglutide, you are looking for what is now called Form Health. Verify current pricing, program structure, and medication availability directly at Form Health's website, as some program details may have changed during the rebranding process.
Is Sequence (Form Health) or Calibrate better for GLP-1?
They serve meaningfully different patient profiles. Form Health (Sequence) is better for patients with complex metabolic situations who specifically need the clinical depth of board-certified obesity medicine specialists and are willing to pay the premium for that specialization. Calibrate is better for insured patients who want brand-name GLP-1 through insurance coordination alongside a structured year-long behavioral coaching program and who will commit to engaging with the coaching fully. For the majority of cash-pay GLP-1 patients with straightforward weight management needs, neither premium platform's specific advantages justify the additional cost over a specialized but moderately priced provider like Luma Health at $197/month flat.
How much does Calibrate cost in 2026?
Calibrate's pricing involves two components. The program fee is approximately $1,649 per year, paid upfront. This covers the platform infrastructure, coaching, and insurance navigation services. The medication cost is separate and depends entirely on insurance approval: for patients who receive prior authorization for brand-name Wegovy or Zepbound and apply the manufacturer savings card, medication can cost as little as $25/month ($300/year). For patients whose insurance denies coverage or doesn't cover weight management medications, the medication must be obtained elsewhere at retail prices. Total annual cost for insured patients with good coverage can approach $1,949; for cash-pay patients, Calibrate's model is not designed as a cash-pay compounded platform and is significantly more expensive than alternatives.
Do I need a premium provider if I have a complex medical history?
If your medical situation involves BMI above 40, multiple obesity-related comorbidities (type 2 diabetes, hypertension, sleep apnea, cardiovascular disease), a history of failed weight loss treatment, or complex medication interactions, the clinical depth of an obesity medicine specialist (Form Health) or a comprehensive metabolic coaching program (Calibrate) may genuinely improve your outcomes. For these patients, the premium is more likely to translate to better clinical management. For patients with a BMI of 27 to 40, relatively straightforward health history, and primarily needing effective GLP-1 medication management, a clinically focused platform like Luma Health provides appropriate clinical oversight at a more sustainable cost.
What happens if Calibrate's insurance coordination fails to get my GLP-1 covered?
This is the most important question to ask Calibrate before enrolling. If your insurance prior authorization for Wegovy or Zepbound is denied, the $1,649 program fee has been paid but your medication is not covered. Calibrate's response to this scenario — whether they offer refunds, alternative medication pathways, or compounded alternatives — should be clarified in writing before you provide payment. The high variability of insurance outcomes for GLP-1 medications makes this a real risk. If your insurance coverage for weight management medications is uncertain, a cash-pay compounded provider with no upfront program fee and month-to-month flexibility is a more financially prudent starting point.
Why would someone choose Luma Health over Sequence or Calibrate?
Luma Health is the right choice when cost predictability and treatment sustainability matter more than clinical subspecialty credentials or comprehensive behavioral coaching. At $197/month flat for semaglutide (or $297/month for tirzepatide), with no annual commitment, no program fee, and all consultations included, Luma Health offers GLP-1 care at a price most patients can sustain for the full 12+ months typically needed to see meaningful weight loss results. The clinical services through Wasef Health, PC and pharmacy through VialsRX (TX Board #35264) provide appropriate clinical oversight for the majority of GLP-1 patients. For patients whose primary need is reliable access to the medication at the best all-in price, Luma Health typically outperforms both premium platforms on value.
Can I switch from Sequence/Form Health or Calibrate to Luma Health?
Yes. Switching providers mid-GLP-1-treatment is clinically straightforward — no titration restart is required when switching between compounded semaglutide providers. Complete the Luma Health intake at start.mylumahealth.com with your current dose information, wait for VialsRX to ship your medication, and continue injecting at your next scheduled weekly dose. For Calibrate patients who received brand-name Wegovy, note that switching to compounded semaglutide means switching medication source (same active ingredient, different manufacturing origin). No washout period is required. Cancel your previous platform after your Luma Health medication ships and you have confirmed treatment continuity.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed
- Rubino DM, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325(14):1414–1425. PubMed
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed
- American Board of Obesity Medicine. ABOM Certification. abom.org
- FDA. Wegovy (semaglutide) Prescribing Information. FDA.gov
- FDA. Human Drug Compounding — Section 503A. FDA.gov
- NABP. Compounding Pharmacy Accreditation. nabp.pharmacy
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov